Immunogenicity of the conjugate and polysaccharide pneumococcal vaccines in high-risk renal patients.
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2016
At a glance
- Drugs Pneumococcal vaccine conjugate; Pneumococcal vaccines
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Sponsors Wyeth
- 13 Aug 2010 United Kingdom Clinical Research Network reports accrual to date as 150%; this was identified via CA tool.
- 13 Aug 2010 Status changed from active, no longer recruiting to completed as reported by United Kingdom Clinical Research Network.
- 13 Aug 2010 Planned end date changed from 16 Apr 2008 to 18 Apr 2008 as reported by UKCRN.